Levetiracetam potentiates the antidyskinetic action of amantadine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease. [electronic resource]
Producer: 20040907Description: 386-94 p. digitalISSN:- 0022-3565
- Amantadine -- therapeutic use
- Animals
- Anticonvulsants -- therapeutic use
- Antiparkinson Agents -- therapeutic use
- Callithrix
- Disease Models, Animal
- Drug Synergism
- Drug Therapy, Combination
- Dyskinesias -- drug therapy
- Female
- Levetiracetam
- Levodopa -- therapeutic use
- MPTP Poisoning -- drug therapy
- Male
- Piracetam -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.